Skip to content

Clinical trials

Neurologic Manifestations trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurologic Manifestations Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20102
20112
20142
20161
20171
20191
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Auspex Pharmaceuticals, Inc.2
ProQR Therapeutics2
Eli Lilly and Company1
Friedreich's Ataxia Research Alliance1
Johann Wolfgang Goethe University Hospital1
Laboratoires Thea1
Marion Mertl-Roetzer1
Novartis1
Novartis Pharmaceuticals1
Sumitomo Pharma Switzerland GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurologic Manifestations13
Central Nervous System Diseases5
Nervous System Diseases5
Brain Diseases4
Blindness3
Eye Abnormalities3
Eye Diseases3
Leber Congenital Amaurosis3
Retinal Diseases3
Sensation Disorders3

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.